Announcement on Convening the Q3 2025 Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Convening the Q3 2025 Performance Briefing
Filed with SSE ·
6ix hasn’t read this filing yet.
Thalys Medical Technology Group Inc. on 6ix
Earlier from Thalys Medical Technology
- Report for Q3 2025
- Announcement on Reply to the Regulatory Inquiry Letter Regarding Matters of Connected Joint Investment
- Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025
- Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
- Announcement on Convening the 2025 Semi-annual Performance Briefing
Later from Thalys Medical Technology
- Announcement on Estimated Guarantee Amount Provided for Holding Subsidiary
- Indicative Announcement on Change in Equity of Shareholder with Over 5% Shares Reaching 5% Scale
- Notice on Convening the 1st Extraordinary General Meeting in 2026
- Indicative Announcement on Stock Trading Risk
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Thalys Medical Technology into a list and get an email when it puts out news.
Follow Thalys Medical Technology